MedTrace Logo

Comparison Between Intrathecal and Intravenous Dexmedetomidine

NCT04374318 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2020-05-07

No results posted yet for this study

Summary

A prospective, randomized, comparative controlled clinical trial, aiming to compare the use of intrathecal dexmedetomidine by intravenous dexmedetomidine in concern of the first request to analgesia. The secondary end-points were the total postoperative analgesic consumption as well as the VAS.

Conditions

  • Postoperative Analgesia

Interventions

DRUG

Dexmedetomidine

INTRATHECAL AND INTRAVENOUS

Sponsors & Collaborators

  • Suez Canal University

    lead OTHER

Principal Investigators

  • Abdelrhman Alshawadfy, MD · Suez Canal University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-01
Primary Completion
2019-10-30
Completion
2020-03-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04374318 on ClinicalTrials.gov